Studying SNAP-25 expression in CSF samples of a large cohort of clinically well-characterised MDD patients, we observed significantly decreased levels compared with control subjects without signs of mental illness, inflammation or neurodegeneration. The gene discussed is SNAP25; the disease is major depressive disorder.